These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 10961352

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Breast cancer chemoprevention. Rational, trials results and future].
    Cutuli B, Lesur A, Namer M, Kerbrat P.
    Bull Cancer; 2009 May; 96(5):519-30. PubMed ID: 19467983
    [Abstract] [Full Text] [Related]

  • 6. National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.
    Vogel VG, Costantino JP, Wickerham DL, Cronin WM.
    Clin Cancer Res; 2003 Jan; 9(1 Pt 2):495S-501S. PubMed ID: 12538506
    [Abstract] [Full Text] [Related]

  • 7. [Chemoprevention of breast cancer: a hope justified?].
    Buser K, Delaloye JF.
    Rev Med Suisse Romande; 2000 Jun; 120(6):511-3. PubMed ID: 11014095
    [Abstract] [Full Text] [Related]

  • 8. The Breast Cancer Continuum: insights from the tamoxifen trials impact future drug development strategies.
    Lewis JP.
    Ann N Y Acad Sci; 2001 Dec; 949():327-32. PubMed ID: 11795371
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Additional effect of SERM: mammary gland].
    Kurebayashi J.
    Clin Calcium; 2004 Oct; 14(10):47-51. PubMed ID: 15577131
    [Abstract] [Full Text] [Related]

  • 14. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N.
    J Natl Cancer Inst; 2005 Nov 16; 97(22):1652-62. PubMed ID: 16288118
    [Abstract] [Full Text] [Related]

  • 15. [Neoadjuvant antihormonal treatment of women with breast cancer].
    Tuxen MK, Kamby C, Nielsen DL.
    Ugeskr Laeger; 2007 Sep 10; 169(37):3077-81. PubMed ID: 17877952
    [Abstract] [Full Text] [Related]

  • 16. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.
    Vogel VG.
    Clin Cancer Res; 2001 Dec 10; 7(12 Suppl):4413s-4418s; discussion 4411s-4412s. PubMed ID: 11916233
    [Abstract] [Full Text] [Related]

  • 17. [New developments in the hormonal treatment of breast cancer in postmenopausal women].
    Trunet P, Marty M.
    Bull Cancer; 1999 Oct 10; 86(10):815-20. PubMed ID: 10572232
    [Abstract] [Full Text] [Related]

  • 18. Tamoxifen in ductal carcinoma in situ.
    Daly MB.
    Semin Oncol; 2006 Dec 10; 33(6):647-9. PubMed ID: 17145343
    [Abstract] [Full Text] [Related]

  • 19. Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.
    Ganz PA, Land SR.
    Menopause; 2008 Dec 10; 15(4 Suppl):797-803. PubMed ID: 18596601
    [Abstract] [Full Text] [Related]

  • 20. Prevention of breast cancer using selective oestrogen receptor modulators (SERMs).
    Powles TJ.
    Breast Cancer Res; 2006 Dec 10; 8(5):111. PubMed ID: 17049068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.